Log In
BCIQ
Print this Print this
 

TPW-182

  Manage Alerts
Collapse Summary General Information
Company Teikoku Seiyaku Co. Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat lateral epicondylitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today